Income Statement (TTM)
ImmuCell Corporation Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 15 | 15 | 15 | 16 | 18 | 19 | 21 | 20 | 20 | 19 | 16 | 16 | 16 | 17 | 21 | 23 | 24 | 26 | 27 | 28 |
Change (%) | 0.73 | -5.24 | 10.84 | 8.86 | 9.69 | 9.83 | -3.22 | -1.73 | -7.63 | -13.75 | -2.05 | 3.83 | 7.28 | 21.81 | 9.12 | 2.65 | 11.14 | 3.06 | 3.56 | |
% of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Cost Of Sales | 8 | 8 | 8 | 9 | 10 | 11 | 11 | 11 | 11 | 10 | 11 | 11 | 12 | 13 | 15 | 17 | 17 | 18 | 18 | 17 |
Change (%) | 4.03 | -2.00 | 9.44 | 8.04 | 7.74 | 3.70 | -2.86 | 2.05 | -5.08 | 2.41 | 3.16 | 10.81 | 8.12 | 13.89 | 11.78 | 1.79 | 7.09 | -1.37 | -3.44 | |
% of Revenue | 53.52 | 55.27 | 57.16 | 56.44 | 56.01 | 55.02 | 51.94 | 52.14 | 54.14 | 55.63 | 66.06 | 69.58 | 74.26 | 74.84 | 69.97 | 71.68 | 71.08 | 68.49 | 65.55 | 61.12 |
Gross Operating Profit | 7 | 7 | 6 | 7 | 8 | 9 | 10 | 10 | 9 | 8 | 5 | 5 | 4 | 4 | 6 | 7 | 7 | 8 | 9 | 11 |
Change (%) | -3.07 | -9.24 | 12.70 | 9.92 | 12.18 | 17.34 | -3.61 | -5.85 | -10.63 | -34.02 | -12.21 | -12.14 | 4.86 | 45.37 | 2.92 | 4.81 | 21.09 | 12.68 | 16.88 | |
% of Revenue | 46.48 | 44.73 | 42.84 | 43.56 | 43.99 | 44.98 | 48.06 | 47.86 | 45.86 | 44.37 | 33.94 | 30.42 | 25.74 | 25.16 | 30.03 | 28.32 | 28.92 | 31.51 | 34.45 | 38.88 |
SG&A | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 5 | 5 | 5 | 5 | 6 | 6 | 6 |
Change (%) | -0.59 | -3.06 | -0.77 | 6.66 | 6.03 | 13.02 | 6.88 | 1.82 | 4.83 | -0.92 | 1.13 | 2.55 | -6.81 | -2.17 | 6.61 | 0.73 | 3.57 | 2.58 | -2.92 | |
% of Revenue | 25.68 | 25.35 | 25.93 | 23.21 | 22.74 | 21.98 | 22.62 | 24.98 | 25.88 | 29.37 | 33.74 | 34.84 | 34.41 | 29.89 | 24.01 | 23.45 | 23.02 | 21.45 | 21.35 | 20.01 |
R&D | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 5 | 5 | 4 | 4 | 5 | 4 | 4 | 4 | 3 | 3 |
Change (%) | 4.76 | 1.30 | -1.96 | -1.75 | -1.90 | 0.12 | 3.32 | 5.15 | -0.89 | 1.66 | -0.86 | -3.34 | 0.39 | 3.46 | -1.52 | -7.42 | -5.96 | -12.97 | -5.85 | |
% of Revenue | 27.29 | 28.38 | 30.34 | 26.84 | 24.22 | 21.66 | 19.75 | 21.08 | 22.56 | 24.20 | 28.53 | 28.87 | 26.88 | 25.15 | 21.36 | 19.28 | 17.39 | 14.72 | 12.43 | 11.30 |
OpEx | 16 | 17 | 16 | 17 | 18 | 19 | 20 | 20 | 21 | 20 | 21 | 21 | 22 | 23 | 25 | 27 | 27 | 28 | 27 | 26 |
Change (%) | 3.10 | -1.39 | 4.06 | 5.27 | 5.10 | 4.99 | 0.77 | 2.66 | -1.66 | 1.35 | 1.74 | 5.59 | 2.79 | 8.17 | 8.24 | 0.02 | 4.33 | -2.19 | -3.63 | |
% of Revenue | 106.49 | 109.00 | 113.43 | 106.49 | 102.98 | 98.66 | 94.31 | 98.20 | 102.59 | 109.21 | 128.33 | 133.29 | 135.55 | 129.88 | 115.34 | 114.41 | 111.49 | 104.65 | 99.32 | 92.43 |
Operating Income | -1 | -1 | -2 | -1 | -1 | 0 | 1 | 0 | -1 | -2 | -5 | -5 | -6 | -5 | -3 | -3 | -3 | -1 | 0 | 2 |
Change (%) | 39.65 | 41.40 | -46.46 | -50.01 | -149.27 | 367.25 | -69.39 | -241.20 | 228.98 | 165.31 | 15.11 | 10.86 | -9.82 | -37.46 | 2.51 | -18.20 | -54.96 | -114.96 | 1,060.16 | |
% of Revenue | -6.49 | -9.00 | -13.42 | -6.49 | -2.98 | 1.34 | 5.69 | 1.80 | -2.59 | -9.21 | -28.33 | -33.29 | -35.55 | -29.88 | -15.34 | -14.41 | -11.49 | -4.65 | 0.68 | 7.57 |
Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -1 | -1 | -1 | -1 | -1 | -1 |
Change (%) | -4.83 | -24.78 | 0.76 | 0.83 | -0.32 | -1.41 | 3.49 | 3.40 | 5.09 | 4.24 | -0.46 | 15.26 | 14.10 | 11.78 | 10.12 | -0.08 | -2.77 | -3.18 | -3.19 | |
% of Revenue | -2.85 | -2.69 | -2.14 | -1.94 | -1.80 | -1.63 | -1.47 | -1.57 | -1.65 | -1.88 | -2.27 | -2.31 | -2.56 | -2.72 | -2.50 | -2.52 | -2.45 | -2.15 | -2.02 | -1.89 |
Net Income | -2 | -1 | -1 | -0 | 0 | -0 | 1 | 0 | -1 | -2 | -5 | -6 | -6 | -6 | -4 | -4 | -4 | -2 | -0 | 2 |
Change (%) | -32.82 | 31.21 | -67.62 | -108.38 | -315.06 | -1,219.27 | -94.18 | -1,573.06 | 231.71 | 113.41 | 13.07 | 4.73 | -8.38 | -32.51 | 3.90 | -5.89 | -43.41 | -87.40 | -748.22 | |
% of Revenue | -9.99 | -6.66 | -9.22 | -2.69 | 0.21 | -0.41 | 4.15 | 0.25 | -3.74 | -13.43 | -33.23 | -38.36 | -38.70 | -33.05 | -18.31 | -17.44 | -15.99 | -8.14 | -1.00 | 6.23 |
Source: Capital IQ